<DOC>
	<DOCNO>NCT02759120</DOCNO>
	<brief_summary>The purpose study compare effect standard care , versus standard care plus antimicrobial therapy ( co-trimoxazole doxycycline ) , clinical outcome patient diagnose idiopathic pulmonary fibrosis ( IPF ) .</brief_summary>
	<brief_title>CleanUP IPF Pulmonary Trials Cooperative</brief_title>
	<detailed_description>This randomize , un-blinded , phase III , multi-center clinical trial antimicrobial therapy strategy idiopathic pulmonary fibrosis patient . Our overall hypothesis reduce harmful microbial impact antimicrobial therapy reduce risk non-elective , respiratory hospitalization death patient Idiopathic Pulmonary Fibrosis ( IPF ) . Subjects randomized 1:1 either receive prescription drug voucher oral antimicrobial therapy form one double strength 160 milligram ( mg ) trimethoprim/800mg sulfamethoxazole ( double strength co-trimoxazole ) twice daily plus folic acid 5 mg daily OR doxycycline 100mg daily weight &lt; 50 kilogram ( kg ) 100mg twice daily weight &gt; 50 kg . Patients randomize receive antimicrobial therapy give co-trimoxazole unless allergy , contraindication co-trimoxazole , renal insufficiency ( glomerular filtration rate ( GFR ) &lt; 30 milliliter ( ml ) ) , hyperkalemic ( potassium &gt; 5 milliequivalent ( mEq ) /liter ( L ) ) , concomitantly take angiotensin convert enzyme inhibitor ( ACEI ) , angiotensin receptor blocker ( ARB ) , potassium spar diuretic case receive doxycycline . Participation study 12 month 42 month depend time enrollment .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<mesh_term>Trimethoprim , Sulfamethoxazole Drug Combination</mesh_term>
	<criteria>1 . â‰¥ 40 year age 2 . Diagnosed idiopathic pulmonary fibrosis ( IPF ) enrol investigator 3 . Signed informed consent 1 . Received antimicrobial therapy past 30 day 2 . Contraindicated antibiotic therapy , include exclusive : 1 . Allergy intolerance tetracycline AND trimethoprim , sulfonamides combination 2 . Allergy intolerance tetracycline AND known potassium level &gt; 5 mEq/L past 6 month . If enrol physician feel potassium level normalize , documentation effect must provide . 3 . Allergy intolerance tetracycline AND concomitant use angiotensinconverting enzyme ( ACEI ) , angiotensin II receptor blocker ( ARB ) , potassium spar diuretic 4 . Allergy intolerance tetracycline AND know glucose6phosphate dehydrogenase deficiency 5 . Allergy intolerance tetracycline AND untreated folate B12 deficiency 6 . Allergy intolerance tetracycline AND know renal insufficiency ( defined glomerular filtration rate ( GFR ) &lt; 30 ml within previous 6 month ) If enrol physician feel renal dysfunction resolve , documentation effect must provide . 3 . Pregnant anticipate become pregnant 4 . Use investigational study agent IPF therapy within past 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Idiopathic Pulmonary Fibrosis</keyword>
	<keyword>IPF</keyword>
	<keyword>pulmonary fibrosis</keyword>
	<keyword>antimicrobial therapy</keyword>
	<keyword>doxycycline</keyword>
	<keyword>co-trimoxazole</keyword>
</DOC>